Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -247.03%-16.74M | -69.79%-33.6M | -32.45%-10.4M | -348.38%-9.94M | 9.60%-8.43M | 27.06%-4.82M | 36.39%-19.79M | -342.00%-7.85M | 147.63%4M | 20.32%-9.33M |
| Net income from continuing operations | -214.42%-14.88M | -14.86%-39.36M | -111.80%-15.96M | -124.96%-11.15M | -26.86%-7.52M | 70.14%-4.73M | -514.63%-34.27M | 44.22%-7.53M | 71.37%-4.96M | -116.73%-5.93M |
| Operating gains losses | -1,607.32%-3.26M | -95.25%285.39K | 133.35%507.89K | ---425.42K | --394.15K | -102.99%-191.22K | 119.94%6.01M | 95.55%-1.52M | ---- | ---- |
| Depreciation and amortization | -14.51%345.4K | -12.67%1.24M | -19.64%260.08K | -7.37%323.56K | -30.45%256.24K | 5.51%404.02K | -6.81%1.42M | -12.69%323.64K | -9.02%349.3K | -4.13%368.43K |
| Securities amortization | ---- | --331.05K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | 569.94%1.57M | 32.84%3.94M | 177.61%1.74M | 31.04%1.15M | 16.41%812.97K | -69.30%234.21K | -59.52%2.96M | -58.49%628.32K | -40.75%874.78K | -68.91%698.35K |
| Deferred tax | ---- | ---297.63K | ---1 | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Other non cashItems | 276.61%1.08M | -86.72%-2.34M | -125.25%-489.91K | 82.86%-408.14K | -32.87%-826.27K | -222.64%-614.13K | -100.69%-1.25M | -95.12%1.94M | -1,537.66%-2.38M | 98.44%-621.87K |
| Change In working capital | -2,143.81%-1.59M | -51.30%2.6M | 289.29%3.2M | -99.22%78.1K | 84.32%-758.94K | -95.89%77.71K | 247.45%5.33M | -139.53%-1.69M | 1,069.21%9.97M | 13.22%-4.84M |
| -Change in receivables | -116.21%-282.95K | -113.59%-408.09K | 399.32%1.84M | -138.59%-3.56M | 87.44%-441.11K | 183.77%1.75M | 110.84%3M | -107.99%-615.61K | 389.04%9.21M | 5.30%-3.51M |
| -Change in payables and accrued expense | 21.75%-1.31M | 29.02%3M | 226.26%1.36M | 379.53%3.63M | 76.08%-317.83K | -141.98%-1.67M | 146.21%2.33M | 68.72%-1.07M | -64.90%757.72K | 28.93%-1.33M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -247.03%-16.74M | -69.79%-33.6M | -32.45%-10.4M | -348.38%-9.94M | 9.60%-8.43M | 27.06%-4.82M | 36.39%-19.79M | -342.00%-7.85M | 147.63%4M | 20.32%-9.33M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 917.26%2.8M | -120.65%-1.13M | -643.36%-211.66K | -87.02%145.72K | -163.86%-724.69K | -110.51%-342.35K | -65.61%5.49M | -100.55%-28.47K | -84.41%1.12M | -68.37%1.13M |
| Net PPE purchase and sale | -0.39%-343.71K | -165.95%-1.04M | -469.62%-162.19K | 35.21%-60.72K | -2,066.32%-479.17K | -37.82%-342.35K | 33.47%-392.72K | 86.77%-28.47K | 66.67%-93.72K | 38.29%-22.12K |
| Net investment purchase and sale | ---101.44K | -101.51%-88.56K | ---49.47K | -83.03%206.43K | -121.22%-245.52K | --0 | -64.46%5.88M | --0 | -83.74%1.22M | -68.07%1.16M |
| Net other investing changes | --3.24M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 917.26%2.8M | -120.65%-1.13M | -643.36%-211.66K | -87.02%145.72K | -163.86%-724.69K | -110.51%-342.35K | -65.61%5.49M | -100.55%-28.47K | -84.41%1.12M | -68.37%1.13M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -66.61%8.74M | 206.97%53M | 14,707.39%21.21M | 98.70%5.8M | -101.23%-170.35K | 3,813.29%26.17M | 80.59%17.27M | -972.58%-145.2K | 3,198.70%2.92M | 202.06%13.83M |
| Net issuance payments of debt | -17.46%-188.17K | 2,270.95%20.31M | 14,424.44%20.8M | 28.07%-159.8K | 46.91%-164.37K | 38.10%-160.2K | -44.83%-935.72K | -674.91%-145.2K | -3.06%-222.15K | -32.59%-309.59K |
| Net common stock issuance | -78.95%6M | 107.62%34.27M | --0 | ---- | ---- | 2,750.60%28.51M | 65.08%16.51M | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --2.96M | -53.37%1.46M | --1.09M | ---- | ---- | --0 | 915.40%3.14M | --0 | ---- | ---- |
| Net other financing activities | 98.34%-36.29K | -110.99%-3.05M | ---679.66K | -73.80%-28.69M | 88.31%28.5M | -2,903.64%-2.18M | -1,314.78%-1.45M | --0 | ---16.51M | 46,930.69%15.13M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -66.61%8.74M | 206.97%53M | 14,707.39%21.21M | 98.70%5.8M | -101.23%-170.35K | 3,813.29%26.17M | 80.59%17.27M | -972.58%-145.2K | 3,198.70%2.92M | 202.06%13.83M |
| Net cash flow | ||||||||||
| Beginning cash position | 265.43%25.08M | 75.94%6.86M | -2.40%14.53M | 170.69%18.54M | 2,191.37%27.86M | 75.94%6.86M | -58.93%3.9M | 3,083.83%14.89M | 331.99%6.85M | -76.29%1.22M |
| Current changes in cash | -124.77%-5.2M | 516.55%18.27M | 231.96%10.59M | -149.75%-4M | -265.61%-9.33M | 882.12%21M | 152.92%2.96M | -333.82%-8.03M | 819.80%8.04M | 258.98%5.63M |
| Effect of exchange rate changes | ---- | ---46.88K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| End cash Position | -28.65%19.88M | 265.43%25.08M | 265.43%25.08M | -2.40%14.53M | 170.69%18.54M | 2,191.37%27.86M | 75.94%6.86M | 75.94%6.86M | 3,083.83%14.89M | 331.99%6.85M |
| Free cash from | -230.69%-17.08M | -71.66%-34.65M | -34.03%-10.57M | -355.89%-10.01M | 4.69%-8.91M | 24.71%-5.16M | 36.33%-20.18M | -295.69%-7.88M | 145.01%3.91M | 20.37%-9.35M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.